Molecular Modelling Analysis of the Metabolism of
Dacarbazine
Fazlul Huq
School of Biomedical Sciences, Faculty of Health Sciences, C42, The
University
of
Sydney,
PO Box 170, Lidcombe, NSW 1825, Australia.Telephone:
+61 2 9351 9522 Fax: +61 2 9351 9520
E-mail :
f.huq@fhs.usyd.edu.au.
Abstract:
Dacarbazine (DTIC) that is routinely used in the treatment of
malignant melanoma, Hodgkin’s disease, renaladenocarcinoma, soft
tissue sarcoma, solid tumours and malignant lymphomas, is a produg
that is metabolized in the liver to produce the active species
responsible for causing DNA methylation. Hydroxylation one of the
methyl groups first produces HMMTIC that yields the unstable
metabolite MTIC following the loss of the hydroxymethyl moiety as
formaldehyde. Spontaneous cleavage of MTIC produces AIC, and the
methylating agent MHAZ. The methylation of DNA is believed to be
responsible for both antineoplastic activity and carcinogenicity. The
adverse effects of DTIC include nausea, vomiting, myelosuppression,
flu-like syndrome and facial flushing. In this study, molecular
modelling analyses have been carried out using the program Spartan ’02
to investigate the relative stability of DTIC and its metabolites, to
locate the positions of negative electrostatic potential and the HOMOS
with high electron density as applied to DTIC and its metabolites,
with the aim of providing a better understanding of toxicity due to
the drug. The results of analyses show that DTIC and its metabolites
differ significantly in their kinetic lability with most having
relatively small LUMO-HOMO energy differences and hence quite labile.
The results of the analyses also show that most of the metabolites may
be subject to electrophilic attack at a number of sites. The location
of HOMOs with high electron density close to O, C and in between the
two nitrogen atoms of MDAZH indicates that the reaction with the
molecule may take place at a number of sites. The presence of HOMOs
with high electron density close to O, C and in between the two
nitrogen atoms of MDAZH indicate that the electrophilic attack on the
molecule may take place at a number of sites.
Key words: Dacarbazine, antitumour activity,
Hodgkin’s disease, methylation, molecular modelling
<<< |